Histologic heterogeneity predicts patient prognosis of HER2-positive metastatic breast cancer: A retrospective study based on SEER database.
Yajie WangYiran LiangFangzhou YeDan LuoYuhan JinYaming LiWenjing ZhaoBing ChenLijuan WangQifeng YangPublished in: Cancer medicine (2023)
Histological subtypes are involved in determining the heterogeneity of HER2+ MBC patient prognosis, which is helpful to guide the prognosis prediction and monitoring of HER2+ breast cancer patients in clinics.